Selection of Influenza A and B Viruses for Resistance to 4‐Guanidino‐Neu5Ac2en in Cell Culture-Reference-Cited by-同舟云学术

Selection of Influenza A and B Viruses for Resistance to 4‐Guanidino‐Neu5Ac2en in Cell Culture

Published:1997-08 Issue:s1 Volume:176 Page:S66-S68
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Colacino Joseph M.,Laver W. Graeme,Air Gillian M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/176/Supplement_1/S66/2797675/176-Supplement_1-S66.pdf

Reference5 articles.

1. Burmeister WP, Ruigrok RWH, Cusack S. The 2.2 A resolution crystal 21. Blick TJ, Tiong T, Sahasrabudhe A, et al. Generation and characterization structure of inOuenza B neuraminidase and its complex with sialic acid. of an inOuenza virus neuraminidase variant with decreased sensitivity to EMBO J 1992; 11:49 0 56. the neuraminidase-speciAEc inhibitor 4-guanidino-Neu5Ac2en. Virology

2. von Itzstein M, Wu WY, Kok GB, etal Rational design of potent sialidase- neuraminidase does not play a role in viral entry, replication, assembly, based inhibitors of inOuenza virus replication. Nature 1993; 363:418 0 or budding. J Virol 1995; 69:1099 0 106. 23. 24. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility;Antimicrobial Agents and Chemotherapy;2018-11

2. Characterization of influenza B virus variants with reduced neuraminidase inhibitor susceptibility;2018-05-30

3. Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance;Antiviral Research;2013-11

4. In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors;Clinical Microbiology and Infection;2011-09

5. Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance;Antimicrobial Agents and Chemotherapy;2010-05